Aprica Pharmaceuticals Pvt. Ltd. Rating Rationales / Reports

Title MID: 90072 14-May-2025 Issuer did not cooperate; Based on best available information; View Report MID: 79010 07-May-2025 Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory; View Report MID: 79010 06-May-2024 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR C; View Report MID: 70965 01-Apr-2024 Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory; View Report MID: 70965 30-Mar-2023 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR B -; Short Term Rating Reaffirmed; View Report MID: 58107 01-Apr-2022 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR B; View Report MID: 46412 28-Dec-2020 Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR B +; Short Term Rating Reaffirmed; View Report MID: 33559 16-Oct-2019 Issuer did not cooperate; Based on best available information; Short Term Rating Reaffirmed; Long Term Rating Downgraded to BWR BB -; View Report MID: 11860 21-Dec-2015 Long Term Rating BWR BB/Stable Assigned; Short Term Rating BWR A4 Assigned; View Report